Company Filing History:
Years Active: 2021-2025
Title: Innovations of Jinduo Yuan in Antibody-Drug Conjugates
Introduction
Jinduo Yuan is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibody-drug conjugates. With a total of four patents to his name, Yuan's work is at the forefront of medical innovation.
Latest Patents
Yuan's latest patents include an "Immobilized endoglycosidase fusion protein and use thereof" and a "Stable antibody-drug conjugate, preparation method therefor, and use thereof." The first patent describes a method for preparing an antibody-drug conjugate through site-directed conjugation based on an N-glycosylation site of an Fc region of an antibody. This method involves providing a donor containing an oxazoline oligosaccharide, an antibody with a GlcNAc motif, and an immobilized endoglycosidase. The process allows for one-step conjugation, enhancing the efficiency of drug development. The second patent focuses on a conjugate and its preparation method, along with a pharmaceutical composition that can be used in the treatment or prevention of diseases.
Career Highlights
Yuan is currently associated with Genequantum Healthcare (Suzhou) Co., Ltd., where he continues to innovate in the field of healthcare. His work has the potential to significantly impact the development of targeted therapies, improving treatment outcomes for various diseases.
Collaborations
Yuan collaborates with notable colleagues such as Gang Qin and Cao Lv, contributing to a dynamic research environment that fosters innovation and advancement in biotechnology.
Conclusion
Jinduo Yuan's contributions to the field of antibody-drug conjugates exemplify the importance of innovation in healthcare. His patents reflect a commitment to improving therapeutic methods and enhancing patient care.